Cosmos Health (NASDAQ:COSM) Stock Crosses Above 50 Day Moving Average – Time to Sell?

Cosmos Health Inc. (NASDAQ:COSM)’s share price crossed above its 50 day moving average during trading on Friday. The stock has a 50 day moving average of $0.30 and traded as high as $0.31. Cosmos Health shares last traded at $0.3079, with a volume of 2,068,763 shares.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on COSM shares. Weiss Ratings restated a “sell (d-)” rating on shares of Cosmos Health in a report on Wednesday. Noble Financial began coverage on shares of Cosmos Health in a research report on Monday. They issued an “outperform” rating for the company. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Cosmos Health has an average rating of “Hold”.

Cosmos Health Stock Up 11.0%

The company has a debt-to-equity ratio of 0.15, a quick ratio of 0.92 and a current ratio of 1.05. The stock has a market capitalization of $30.98 million, a PE ratio of -0.48 and a beta of 4.69. The business has a 50 day moving average of $0.30 and a two-hundred day moving average of $0.31.

Cosmos Health (NASDAQ:COSM) last issued its quarterly earnings data on Tuesday, August 18th. The company reported ($0.10) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.10). The company had revenue of $19.32 million for the quarter, compared to the consensus estimate of $18.99 million. Cosmos Health had a negative return on equity of 56.88% and a negative net margin of 33.08%. Analysts predict that Cosmos Health Inc. will post -0.15 EPS for the current year.

Institutional Inflows and Outflows

A hedge fund recently bought a new position in Cosmos Health stock. BlackRock Inc. bought a new stake in Cosmos Health Inc. (NASDAQ:COSM) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 267,797 shares of the company’s stock, valued at approximately $49,000. BlackRock Inc. owned approximately 0.45% of Cosmos Health as of its most recent SEC filing. Institutional investors own 12.61% of the company’s stock.

About Cosmos Health

Cosmos Health Inc is a healthcare group that develops, manufactures and distributes pharmaceutical, nutraceutical and healthcare products. Its portfolio includes branded dietary supplements, vitamins and wellness products, as well as pharmaceutical products and medical devices distributed through retail, wholesale and online channels.

The company markets its nutraceutical products under the Sky Premium Life brand, which offers supplements and other health and wellness products. Cosmos Health also has manufacturing and product-development activities through Cana Laboratories, a Greece-based pharmaceutical manufacturer that produces pharmaceutical and healthcare products for its own portfolio and third parties.

Founded in 2009 and formerly known as Cosmos Holdings, the company adopted the Cosmos Health name in 2022.